Not all aggressive adult T-cell leukemia/lymphoma subtypes are created equal

J Clin Oncol. 2012 Oct 1;30(28):3560; author reply 3561. doi: 10.1200/JCO.2012.43.5016. Epub 2012 Aug 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Female
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell / mortality*
  • Leukemia-Lymphoma, Adult T-Cell / pathology*
  • Male
  • Receptors, Interleukin-2 / blood*

Substances

  • Receptors, Interleukin-2